Iron Deficiency Anemia

ClinicalJune 25, 2026

IRON-DEP Study Evaluates IV vs Oral Iron for Postpartum Depression in Anemia

The IRON-DEP Study aims to compare the efficacy of intravenous and oral iron treatments on postpartum depression prevalence in women with moderate iron deficiency anemia post-caesarean.

Relevant assets

Relevant companies

Recent signals(7)

FDA Grants Approval for Ferric Carboxymaltose by Mylan

FDA Grants Approval for Ferric Carboxymaltose by Mylan Labs

FDA Approves Ferric Carboxymaltose for Mylan's ANDA217076

FDA Grants Approval for Mylan's Ferric Carboxymaltose ANDA217076

FDA Approves Ferric Carboxymaltose ANDA212572 by Mylan Labs

FDA Approves ANDA217769 for Ferric Carboxymaltose by Mylan

IRON-DEP Study Evaluates IV vs Oral Iron for Postpartum Depression in Anemia

Upcoming catalysts

Therapeutic areas

Get signals before the market moves